FIELD OF THE INVENTION
The present invention is directed to the use of Tellimagrandin II for the inhibition of Gram-positive bacteria growth, the anti-inflammation and the treatment of leukemia.
BACKGROUND OF THE INVENTION
Anti-Bacterial Infection
Staphylococcus aureus (SA) belongs to Gram-positive